Another study discovered that quercetin alone or in conjunction with sorafenib, the first drug approved to treat advanced hepatocellular carcinoma, all downregulated the anti-inflammatory, proliferative, and angiogenesis-related genes TNF-, VEGF, P53, and NF-B. This evidence concerns the gene TP53 and hepatocellular carcinoma.